Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%

Detalles Bibliográficos
Autores principales: Naumann, U, Moll, A, Schleehauf, D, Lutz, KT, Schmidt, W, Jaeger, H, Funke, B, Witte, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535805/
https://www.ncbi.nlm.nih.gov/pubmed/31112487
http://dx.doi.org/10.1177/0956462418812642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535805/
https://www.ncbi.nlm.nih.gov/pubmed/31112487
http://dx.doi.org/10.1177/0956462418812642

Ejemplares similares